BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19963078)

  • 1. Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.
    Zimic M; Sheen P; Quiliano M; Gutierrez A; Gilman RH
    Infect Genet Evol; 2010 Mar; 10(2):346-9. PubMed ID: 19963078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
    Zimic M; Fuentes P; Gilman RH; Gutiérrez AH; Kirwan D; Sheen P
    Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.
    Rodrigues Vde F; Telles MA; Ribeiro MO; Cafrune PI; Rossetti ML; Zaha A
    Antimicrob Agents Chemother; 2005 Jan; 49(1):444-6. PubMed ID: 15616332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China.
    Zhang H; Bi LJ; Li CY; Sun ZG; Deng JY; Zhang XE
    J Int Med Res; 2009; 37(5):1430-5. PubMed ID: 19930847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
    Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y
    Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.
    Miotto P; Cabibbe AM; Feuerriegel S; Casali N; Drobniewski F; Rodionova Y; Bakonyte D; Stakenas P; Pimkina E; Augustynowicz-Kopeć E; Degano M; Ambrosi A; Hoffner S; Mansjö M; Werngren J; Rüsch-Gerdes S; Niemann S; Cirillo DM
    mBio; 2014 Oct; 5(5):e01819-14. PubMed ID: 25336456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.
    Yoon JH; Nam JS; Kim KJ; Ro YT
    World J Microbiol Biotechnol; 2014 Nov; 30(11):2821-8. PubMed ID: 25034468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan.
    Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3672-3. PubMed ID: 14576145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
    Mestdagh M; Fonteyne PA; Realini L; Rossau R; Jannes G; Mijs W; De Smet KA; Portaels F; Van den Eeckhout E
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2317-9. PubMed ID: 10471589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis.
    Aono A; Chikamatsu K; Yamada H; Kato T; Mitarai S
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4928-30. PubMed ID: 24867972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis.
    Sheen P; Ferrer P; Gilman RH; López-Llano J; Fuentes P; Valencia E; Zimic MJ
    Tuberculosis (Edinb); 2009 Mar; 89(2):109-13. PubMed ID: 19249243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
    BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA.
    Lemaitre N; Sougakoff W; Truffot-Pernot C; Jarlier V
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1761-3. PubMed ID: 10390238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
    Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y
    Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil.
    Barco P; Cardoso RF; Hirata RD; Leite CQ; Pandolfi JR; Sato DN; Shikama ML; de Melo FF; Mamizuka EM; Campanerut PA; Hirata MH
    J Antimicrob Chemother; 2006 Nov; 58(5):930-5. PubMed ID: 16971417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and phenotypic characterization of pyrazinamide-resistant mycobacterium tuberculosis complex isolates in Japan.
    Miyagi C; Yamane N; Yogesh B; Ano H; Takashima T
    Diagn Microbiol Infect Dis; 2004 Feb; 48(2):111-6. PubMed ID: 14972380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of pyrazinamidase activity using a cell-free
    Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
    Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms.
    Sreevatsan S; Pan X; Zhang Y; Kreiswirth BN; Musser JM
    Antimicrob Agents Chemother; 1997 Mar; 41(3):636-40. PubMed ID: 9056006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates.
    Mestdagh M; Realini L; Fonteyne PA; Rossau R; Jannes G; Mijs W; DE Smet KA; Portaels F; Van den Eeckhout E
    Microb Drug Resist; 2000; 6(4):283-7. PubMed ID: 11272256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.
    Muthaiah M; Jagadeesan S; Ayalusamy N; Sreenivasan M; Prabhu SS; Muthuraj U; Senthilkumar K; Veerappan S
    Int J Mol Sci; 2010 Jul; 11(7):2670-80. PubMed ID: 20717529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.